Know. Before.
See which cancer treatment is the most effective.
Introducing cResponse™
The cResponse™ test evaluates up to eight therapies suggested by the oncologist—including chemotherapy, biologics, and immunotherapies—by assessing their performance on a patient’s biopsy. The test preserves the tumor’s 3D structure and microenvironment, achieving exceptionally high prediction accuracy rates.
cResponse™ in Numbers
Accuracy predicting treatment efficacy and therapy resistance, supporting informed and effective decisions.
Of patients get actionable insights for optimized treatment plans; the remaining benefit from treatment choice confirmation.
Of all cancer types are covered, with a primary focus on solid tumors, for broad clinical applicability.
Of available treatments evaluated: chemotherapy, biological therapies, immunotherapies, & their combinations.
Next Generation in
Cancer Precision Medicine
As each tumor is unique, each patient will respond differently to anti-cancer therapies. While genomic sequencing of tumors can help some patients to select the right treatment, most patients will not benefit from this technology, and their response to therapy (whether selected by genomic testing or not) will be unpredictable.
The cResponse™ test is a first-of-its-kind combined Genomic-Functional assay. The test starts with genomic profiling of the tumor to prioritize potential therapies. Then, together with additional therapies that were recommended by the patient’s oncologist, a short list of drugs and drug combinations is generated and functionally tested on the patient’s tumor.
The cResponse™ functional test preserves the original tumor composition (commonly referred to as the Tumor MicroEnvironment – TME) and its 3D structure to assess the effectiveness of all selected treatments on the tumor cells. This enables cResponse™ to empirically analyze the effectiveness of the recommended treatments following rapid genomic profiling with very high accuracy.
Hear what patients say
Watch the Video
“I went through all the possible genomic tests… Yet, the results did not help me evaluate my treatment position… The first time I felt confident in a test result, it was with the cResponse test.”
Orna, cResponse™ Patient
